Connor, Clark & Lunn Investment Management Ltd. - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 135 filers reported holding IMMUNOVANT INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$9,489,317
+238.4%
247,182
+67.2%
0.05%
+257.1%
Q2 2023$2,803,842
+189.8%
147,804
+136.9%
0.01%
+180.0%
Q1 2023$967,560
+107.9%
62,383
+137.9%
0.01%
+66.7%
Q4 2022$465,387
+356.3%
26,219
+42.9%
0.00%
+200.0%
Q3 2022$102,000
-58.5%
18,352
-58.9%
0.00%0.0%
Q1 2022$246,000
-81.4%
44,668
-71.2%
0.00%
-83.3%
Q4 2021$1,321,000
+94.8%
155,041
+98.6%
0.01%
+50.0%
Q3 2021$678,00078,0510.00%
Other shareholders
IMMUNOVANT INC shareholders Q4 2022
NameSharesValueWeighting ↓
Alpine Global Management, LLC 3,000,200$26,072,0005.92%
MANGROVE PARTNERS IM, LLC 1,139,900$9,906,0000.89%
Eventide Asset Management 4,950,000$43,016,0000.57%
Ghost Tree Capital, LLC 200,000$1,738,0000.51%
WITTENBERG INVESTMENT MANAGEMENT, INC. 140,500$1,221,0000.47%
FRAZIER MANAGEMENT LLC 585,759$5,090,0000.41%
MANGROVE PARTNERS IM, LLC 500,000$4,345,0000.39%
EcoR1 Capital, LLC 1,140,819$9,914,0000.34%
BCK CAPITAL MANAGEMENT LP 53,459$465,0000.28%
PLATINUM INVESTMENT MANAGEMENT LTD 555,065$4,824,0000.14%
View complete list of IMMUNOVANT INC shareholders